Aoife Brennan

About

Aoife Brennan, M.D. (M.B., Ch.B.) is a biotech executive focused on drug development across rare disease, immunology, oncology, and broader biopharma R&D. As of the sources reviewed, she is President and CEO of Climb Bio and serves on the boards of Xilio Therapeutics, FibroGen, and Cerevance. She previously served as CEO, President, and board member of Synlogic and earlier led Biogen's Rare Disease Innovation Unit.

Areas of interest